A detailed history of First Trust Advisors LP transactions in Natera, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 1,130,572 shares of NTRA stock, worth $120 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,130,572
Previous 114,925 883.75%
Holding current value
$120 Million
Previous $7.2 Million 1336.54%
% of portfolio
0.11%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $60.1 Million - $94.4 Million
1,015,647 Added 883.75%
1,130,572 $103 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $9.98 Million - $16.6 Million
-265,683 Reduced 69.8%
114,925 $7.2 Million
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $12.2 Million - $17.5 Million
-280,205 Reduced 42.4%
380,608 $16.8 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $23.2 Million - $27.2 Million
493,551 Added 295.08%
660,813 $32.2 Million
Q1 2023

May 15, 2023

SELL
$36.57 - $58.29 $15 Million - $23.9 Million
-409,887 Reduced 71.02%
167,262 $9.29 Million
Q4 2022

Feb 09, 2023

BUY
$34.17 - $47.91 $19.3 Million - $27 Million
564,400 Added 4427.01%
577,149 $23.2 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $470,820 - $722,613
12,749 New
12,749 $559,000
Q2 2022

Aug 12, 2022

SELL
$28.13 - $44.54 $209,399 - $331,555
-7,444 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $4.23 Million - $12.7 Million
-139,551 Reduced 94.94%
7,444 $303,000
Q4 2021

Feb 08, 2022

SELL
$86.26 - $119.0 $5.7 Million - $7.86 Million
-66,080 Reduced 31.01%
146,995 $13.7 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $17.9 Million - $22.6 Million
178,546 Added 517.09%
213,075 $23.7 Million
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $1.64 Million - $2.28 Million
-19,068 Reduced 35.58%
34,529 $3.92 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $1.96 Million - $2.66 Million
-21,418 Reduced 28.55%
53,597 $5.44 Million
Q4 2020

Feb 02, 2021

BUY
$66.66 - $111.74 $2.54 Million - $4.26 Million
38,115 Added 103.29%
75,015 $7.47 Million
Q3 2020

Nov 05, 2020

BUY
$45.89 - $72.67 $54,012 - $85,532
1,177 Added 3.29%
36,900 $2.67 Million
Q2 2020

Jul 22, 2020

SELL
$26.36 - $49.86 $144,189 - $272,734
-5,470 Reduced 13.28%
35,723 $1.78 Million
Q1 2020

May 06, 2020

SELL
$17.27 - $40.17 $511,347 - $1.19 Million
-29,609 Reduced 41.82%
41,193 $1.23 Million
Q4 2019

Feb 03, 2020

BUY
$32.1 - $40.4 $2.27 Million - $2.86 Million
70,802 New
70,802 $2.39 Million
Q2 2019

Jul 30, 2019

SELL
$17.75 - $27.58 $470,250 - $730,676
-26,493 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$11.34 - $20.62 $1.98 Million - $3.61 Million
-174,997 Reduced 86.85%
26,493 $546,000
Q4 2018

Feb 07, 2019

BUY
$12.32 - $24.38 $2.48 Million - $4.91 Million
201,490 New
201,490 $2.81 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.